Echelon Biosciences

Echelon Biosciences is a long-established, privately-held provider of specialized research tools and services centered on lipid and cell signaling biology. The company's business model combines the sale of catalog products (including lipids, peptides, antibodies, and assay kits) with high-value contract services such as custom synthesis, lipid nanoparticle (LNP) formulation, assay services, and nanobody production. With decades of expertise from its academic founders, Echelon serves as a critical enabler for early-stage research, positioning itself at the intersection of diagnostics, drug discovery, and the rapidly growing field of lipid-based therapeutics and delivery systems.

Integrated platform of custom lipid/peptide synthesis, assay development, and lipid nanoparticle (LNP) formulation services, built on decades of expertise in lipid chemistry and cell signaling biology.

Echelon competes with large, diversified life science tool companies (e.g., MilliporeSigma, Thermo Fisher) and specialized lipid suppliers like Avanti Polar Lipids (Croda) and Cayman Chemical. Its differentiation lies in its deep expertise, custom synthesis capabilities, and integrated service offerings (especially LNP formulation), which larger players may not provide with the same level of specialization and collaboration.